(Q29614851)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

7

Ashe KH

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

author name string

Cleary JP

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

Walsh DM

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

Hofmeister JJ

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

Shankar GM

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

Kuskowski MA

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

Selkoe DJ

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

January 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

volume

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

page(s)

79-84

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

30 April 2017

issue

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

30 April 2017

cites work

1 reference

Alzheimer's disease is a synaptic failure

1 May 2017

1 reference

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 May 2017

1 reference

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 May 2017

1 reference

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

1 May 2017

1 reference

7 January 2021

The molecular pathology of Alzheimer's disease

1 reference

7 January 2021

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

1 reference

7 January 2021

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

1 reference

7 January 2021

Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity

1 reference

7 January 2021

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

7 January 2021

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

1 reference

7 January 2021

1 reference

7 January 2021

APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1.

1 reference

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

7 January 2021

Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice.

1 reference

7 January 2021

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

1 reference

7 January 2021

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

7 January 2021

Correlations of synaptic and pathological markers with cognition of the elderly

1 reference

7 January 2021

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

1 reference

7 January 2021

Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person

1 reference

7 January 2021

Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques.

1 reference

7 January 2021

Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

1 reference

7 January 2021

Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as

1 reference

7 January 2021

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

7 January 2021

Reversible memory loss in a mouse transgenic model of Alzheimer's disease

1 reference

7 January 2021

Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

1 reference

7 January 2021

The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain

1 reference

7 January 2021

Alternating lever cyclic-ratio schedule analysis of the effects of atropine sulfate.

1 reference

7 January 2021

Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Abeta(1-42) injections in the rat.

1 reference

7 January 2021

A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits

1 reference

7 January 2021

The scopolamine-induced impairment of spatial cognition parallels the acetylcholine release in the ventral hippocampus in rats.

1 reference

7 January 2021

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

1 reference

7 January 2021

Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42).

1 reference

7 January 2021

Beta-amyloid(1-40) effects on behavior and memory.

1 reference

7 January 2021

Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology

1 reference

7 January 2021

Intrahippocampal injections of exogenous beta-amyloid induce postdelay errors in an eight-arm radial maze.

1 reference

7 January 2021

Effects of an exogenous beta-amyloid peptide on retention for spatial learning.

1 reference

7 January 2021

Patterns of brain activation in people at risk for Alzheimer's disease.

1 reference

7 January 2021

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease

1 reference

7 January 2021

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease

1 reference

7 January 2021

Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques

1 reference

7 January 2021

Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits

1 reference

7 January 2021

Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease

1 reference

7 January 2021

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

2588097

1022501536

0 references

2588097

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=15608634

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017